01—Abstract
Summary
Summary of the 8-K filed February 26, 2025. Cited figures are marked; the original filing is the authoritative source.
Verisk Analytics, Inc. furnished a press release announcing fourth-quarter and full-year 2024 results.
Fourth-quarter consolidated revenues were $736 milliona, up 8.6% on a consolidated and organic constant currency (OCC) basis. For full-year 2024, revenues were $2,882 million, up 7.5% (7.1% on an OCC basis), and adjusted EBITDA was $1,576 million, up 9.9%. Full-year income from continuing operations rose 23.7% to $951 million, aided by a net gain of $100.6 million from the settlement of retained interests tied to prior divestitures.
Diluted EPS attributable to Verisk was $6.66b, up 27.6%, and diluted adjusted EPS was $6.64, up 16.3%. Free cash flow for the year was $920 million, up 10.8%. The company announced a 15% dividend increase, with the Board approving $0.45 per share payable March 31, 2025, and approved an additional share repurchase authorization of up to $1.0 billion.
At December 31, 2024, $592 millionc remained under the prior authorization. During the fourth quarter, Verisk entered into and fully funded a $300 million accelerated share repurchase program.
For fiscal 2025, management guided to revenue of $3,030 million to $3,080 milliond, adjusted EBITDA of $1,670 million to $1,720 million, an adjusted EBITDA margin of 55.0% to 55.8%, and diluted adjusted EPS of $6.80 to $7.10. The guidance incorporates the divestiture of the Atmospheric and Environmental Research (AER) business, which was sold in December 2024 for $7.1 million with a loss of $12.1 million.
02—Key points
Key Highlights
- Q4 2024 revenues of $736 million, up 8.6% on a consolidated and OCC basis; underwriting revenues rose 6.8% and claims revenues rose 13.0%.
- Full-year 2024 revenues of $2,882 million, up 7.5% (7.1% OCC); adjusted EBITDA of $1,576 million, up 9.9%.
- Full-year diluted EPS attributable to Verisk of $6.66, up 27.6%; diluted adjusted EPS of $6.64, up 16.3%.
- Full-year income from continuing operations of $951 million, up 23.7%, including a $100.6 million net gain from settlement of retained interests.
- Dividend increased 15% to $0.45 per share, payable March 31, 2025; additional $1.0 billion share repurchase authorization approved.
- 2025 guidance: revenue of $3,030 million to $3,080 million, adjusted EBITDA of $1,670 million to $1,720 million, and diluted adjusted EPS of $6.80 to $7.10.
- Full-year free cash flow of $920 million, up 10.8%; $300 million accelerated share repurchase program fully funded in Q4 2024.
03—Questions
Frequently Asked Questions
How did Verisk perform in the fourth quarter and full year of 2024?
Q4 2024 consolidated revenues were $736 million, up 8.6% on a consolidated and OCC basis. Full-year revenues were $2,882 million, up 7.5% (7.1% OCC), and full-year adjusted EBITDA was $1,576 million, up 9.9%.
Did one-time items affect 2024 earnings?
Yes. Full-year income from continuing operations included a net gain of $100.6 million from the settlement of retained interests related to prior sales of the healthcare business in 2016 and the specialized markets business in 2022. The prior year included a litigation reserve expense of $38.2 million tied to the former Financial Services segment.
What is Verisk's capital return plan?
The Board approved a cash dividend of $0.45 per share, a 15% increase from the 39 cents paid on December 31, 2024, payable March 31, 2025. The Board also approved an additional share repurchase authorization of up to $1.0 billion, on top of $592 million remaining as of December 31, 2024.
What guidance did Verisk provide for fiscal 2025?
Verisk guided to revenue of $3,030 million to $3,080 million, adjusted EBITDA of $1,670 million to $1,720 million, an adjusted EBITDA margin of 55.0% to 55.8%, and diluted adjusted EPS of $6.80 to $7.10. The guidance reflects the AER divestiture and current foreign exchange and interest rates.
04—Continue